Mary Rozenman is the founder of Insitro. Insitro has raised $150M in total funding. Latest round: Series C. Based in Hillsborough, CA, USA.
Mary Rozenman serves as CFO/CBO at Insitro, a company leveraging machine learning and human biology to develop new medicines. She earned her Ph.D. in Organic Chemistry and Chemical Biology from Harvard University and a B.A. in Biochemistry and Russian Literature from Columbia University. Rozenman was born in Moscow, Russia and currently resides in Hillsborough, CA.
Full founder directory · Investor directory · Company funding database · Fundraising library